Strategic question
How does Singapore’s Digital Health ecosystem compare globally, and where should national policy and investment focus?
How Galen Growth helped
From market signal to decision-ready evidence
Powered by HealthTech Alpha, we ran global comparative benchmarking across venture landscapes, investment trends, reimbursement models and talent, aligning findings to Singapore’s RIE2030 objectives.
Outcomes
Identified clear ecosystem gaps, competitiveness levers and priority investment areas relative to global peers.
Decision enabled: Enabled the agency to shape national programme design and strategic investment priorities with comparative evidence.
Key results
Our approach
A repeatable path to a defensible decision
Define
Clarify the strategic question, decision owner, market boundaries, and success criteria.
Map
Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.
Assess
Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.
Decide
Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.
Related work
More digital health case studies
Tracking Competitor Moves to Support Global Franchise Strategy
How should we track competitor activity across obesity, diabetes and cardiovascular disease to support global strategic decisions?
Prioritising Markets and Partners to Accelerate a Women’s Health Roadmap
Which priority markets and venture partners should anchor our future women’s health innovation roadmap, starting with telemedicine?
Sourcing OMICS Ventures to Shape Oncology and Wellness Strategy
Which OMICS-led ventures tackling oncology and wellness are mature enough to partner with an enterprise insurer?